292 related articles for article (PubMed ID: 17583355)
1. Pharmacology of N-desmethylclozapine.
Lameh J; Burstein ES; Taylor E; Weiner DM; Vanover KE; Bonhaus DW
Pharmacol Ther; 2007 Aug; 115(2):223-31. PubMed ID: 17583355
[TBL] [Abstract][Full Text] [Related]
2. The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D₂ and serotonin 5-HT₁A receptors.
Heusler P; Bruins Slot L; Tourette A; Tardif S; Cussac D
Eur J Pharmacol; 2011 Nov; 669(1-3):51-8. PubMed ID: 21835172
[TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus properties of N-desmethylclozapine, the major active metabolite of the atypical antipsychotic clozapine, in C57BL/6 mice.
Wiebelhaus JM; Vunck SA; Meltzer HY; Porter JH
Behav Pharmacol; 2012 Jun; 23(3):262-70. PubMed ID: 22547022
[TBL] [Abstract][Full Text] [Related]
4. Clozapine and global cognition in schizophrenia.
Rajji TK; Uchida H; Ismail Z; Ng W; Mamo DC; Remington G; Pollock BG; Mulsant BH
J Clin Psychopharmacol; 2010 Aug; 30(4):431-6. PubMed ID: 20631560
[TBL] [Abstract][Full Text] [Related]
5. N-Desmethylclozapine, a major clozapine metabolite, acts as a selective and efficacious delta-opioid agonist at recombinant and native receptors.
Onali P; Olianas MC
Neuropsychopharmacology; 2007 Apr; 32(4):773-85. PubMed ID: 16841075
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic effects of N-desmethylclozapine on sensorimotor gating function in rats--possible involvement of activation of M(1) muscarinic receptors.
Maehara S; Satow A; Hikichi H; Ohta H
Eur J Pharmacol; 2011 Sep; 667(1-3):242-9. PubMed ID: 21658379
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of N-desmethylclozapine on locomotor activity and sensorimotor gating function in mice-Possible involvement of muscarinic receptors.
Maehara S; Hikichi H; Ohta H
Brain Res; 2011 Oct; 1418():111-9. PubMed ID: 21917240
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies.
Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
Neuropsychopharmacology; 2007 Jul; 32(7):1540-9. PubMed ID: 17164815
[TBL] [Abstract][Full Text] [Related]
9. N-desmethylclozapine: is there evidence for its antipsychotic potential?
Mendoza MC; Lindenmayer JP
Clin Neuropharmacol; 2009; 32(3):154-7. PubMed ID: 19483482
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological evidence showing muscarinic agonist-antagonist activities of N-desmethylclozapine using hippocampal excitatory and inhibitory neurons.
Sugawara Y; Kikuchi Y; Yoneda M; Ohno-Shosaku T
Brain Res; 2016 Jul; 1642():255-262. PubMed ID: 27048752
[TBL] [Abstract][Full Text] [Related]
11. The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?
Davies MA; Compton-Toth BA; Hufeisen SJ; Meltzer HY; Roth BL
Psychopharmacology (Berl); 2005 Apr; 178(4):451-60. PubMed ID: 15765260
[TBL] [Abstract][Full Text] [Related]
12. N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors.
Li Z; Huang M; Ichikawa J; Dai J; Meltzer HY
Neuropsychopharmacology; 2005 Nov; 30(11):1986-95. PubMed ID: 15900318
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of neuroleptics in use in the United States.
Richelson E
J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):8-14. PubMed ID: 2862140
[TBL] [Abstract][Full Text] [Related]
14. Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo.
Humbert-Claude M; Davenas E; Gbahou F; Vincent L; Arrang JM
Psychopharmacology (Berl); 2012 Mar; 220(1):225-41. PubMed ID: 21912901
[TBL] [Abstract][Full Text] [Related]
15. [Clinical psychopharmacology: the example of clozapine (Leponex)].
Péré JJ
Encephale; 1995 Jun; 21 Spec No 3():9-12. PubMed ID: 7628347
[TBL] [Abstract][Full Text] [Related]
16. Plasma ratio of clozapine to N-desmethylclozapine can predict cognitive performance in treatment-resistant psychotic patients.
Molins C; Carceller-Sindreu M; Navarro H; Carmona C; Piñeiro M; Martínez E; Álvarez E; Portella MJ
Psychiatry Res; 2017 Dec; 258():153-157. PubMed ID: 29024893
[TBL] [Abstract][Full Text] [Related]
17. The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus.
Ertuğrul A; Ozdemir H; Vural A; Dalkara T; Meltzer HY; Saka E
Brain Res Bull; 2011 Feb; 84(2):144-50. PubMed ID: 21134422
[TBL] [Abstract][Full Text] [Related]
18. The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats.
Prus AJ; Pehrson AL; Philibin SD; Wood JT; Vunck SA; Porter JH
Psychopharmacology (Berl); 2009 Apr; 203(2):295-301. PubMed ID: 18685832
[TBL] [Abstract][Full Text] [Related]
19. An overview of the mechanism of action of clozapine.
Meltzer HY
J Clin Psychiatry; 1994 Sep; 55 Suppl B():47-52. PubMed ID: 7961573
[TBL] [Abstract][Full Text] [Related]
20. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
